copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Novartis receives approval for first malaria medicine for newborn . . . Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by Swiss agency for therapeutic products (Swissmedic) Novartis plans to introduce infant-friendly Coartem Baby on largely not-for-profit basis to increase access in areas where
Novartis wins approval for first malaria drug for newborns Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter Novartis has won approval in Switzerland for the world’s first malaria drug for newborns and infants
Novartis gets approval of first malaria medicine for newborns Dive Brief: Novartis won regulatory approval Tuesday of the first malaria medicine for newborns and the youngest infants, who until now had no treatment specifically available for them Regulators in Switzerland cleared the pharmaceutical company’s Coartem Baby, which is a new formulation of a two-drug regimen that for years has been used against malaria in children over 2 months old